BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 302045)

  • 1. Cell-mediated immunity to measles virus in subacute sclerosing panencephalitis.
    Yamanaka T; Chiba S; Nakao T; Okabe N; Takahashi N
    Tohoku J Exp Med; 1977 Jun; 122(2):175-81. PubMed ID: 302045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
    Kreth WH; Käckell MY; ter Meulen V
    J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis.
    Steele RW; Fuccillo DA; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1976 Jan; 88(1):56-62. PubMed ID: 812971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity against measles virus in SSPE. I. Enhancement by antibody.
    Kreth HW; Meulen V
    J Immunol; 1977 Jan; 118(1):291-5. PubMed ID: 830752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of measles virus antigen(s) in peripheral lymphocytes from patients with subacute sclerosing panencephalitis.
    Wrzos H; Kulczycki J; Laskowski Z; Matacz D; Brzosko WJ
    Arch Virol; 1979; 60(3-4):291-7. PubMed ID: 389202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; Jacobson S; McFarlin DE; McFarland HF
    Ann Neurol; 1989 Mar; 25(3):272-80. PubMed ID: 2786368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological response of subacute sclerosing panencephalitis patients to measles virus.
    Madden DL; Fuccillo DA; Castellano G; Traub R; Krezlewicz A; Sever JL
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):509-20. PubMed ID: 616551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated cytotoxicity against measles virus in SSPE. II. Analysis of cytotoxic effector cells.
    Kreth HW; Wiegand G
    J Immunol; 1977 Jan; 118(1):296-301. PubMed ID: 830753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.
    Hara T; Yamashita S; Aiba H; Nihei K; Koide N; Good RA; Takeshita K
    J Neurovirol; 2000 Apr; 6(2):121-6. PubMed ID: 10822325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Abernathy M; Vincent MM; Hensen SA; Bellanti JA
    Clin Immunol Immunopathol; 1976 Mar; 5(2):165-72. PubMed ID: 1084246
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity.
    Labowskie R; Edelman R; Rustigian R; Bellanti JA
    J Infect Dis; 1974 Mar; 129(3):233-9. PubMed ID: 4816303
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of lymphocytes from subacute sclerosing panencephalitis patients by defined measles virus antigens.
    Ilonen J; Reunanen M; Herva E; Ziola B; Salmi A
    Cell Immunol; 1980 May; 51(2):201-14. PubMed ID: 6966188
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell mediated immunity in patients with subacute sclerosing panencephalitis.
    Aysun S; Sanal O; Renda Y; Berkel I; Yalaz K; Ersoy F; Ozdirim E
    Brain Dev; 1984; 6(4):391-6. PubMed ID: 6333831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis.
    Dhib-Jalbut S; McFarland HF; Mingioli ES; Sever JL; McFarlin DE
    J Virol; 1988 Jul; 62(7):2483-9. PubMed ID: 3373575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in SSPE patients.
    Kreth HW; Kaeckell YM; ter Meulen V
    Med Microbiol Immunol; 1974; 160(2-3):191-9. PubMed ID: 4614050
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.
    Hall WW; Lamb RA; Choppin PW
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2047-51. PubMed ID: 287042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [State of the cellular component of immunity in subacute sclerosing panencephalitis in children].
    Mitrokhina LA; Lebenzon SS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(10):1478-80. PubMed ID: 6606914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines.
    Thurman GB; Ahmed A; Strong DM; Knudsen RC; Grace WR; Sell KW
    J Exp Med; 1973 Oct; 138(4):839-46. PubMed ID: 4355279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological studies on the etiological role of measles-like virus in subacute sclerosing panencephalitis.
    Polna I; Cendrowski W
    J Neurol; 1977 Nov; 216(4):301-10. PubMed ID: 72813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute sclerosing panencephalitis (SSPE).
    Lapointe N; Geoffroy G; McLaughlin B; Mongeau JG
    Birth Defects Orig Artic Ser; 1975; 11(1):239-43. PubMed ID: 1096980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.